This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results
Filter
Subject / Keyword
Author / Creator / Contributor
Year
Collections
Languages
Item type
Departments
-
Buparvaquone Nanostructured Lipid Carrier Development: Physicochemical and In Vitro Leishmanicidal Performances
DownloadSpring 2018
Leishmaniases is a group of diseases caused by parasites of the genus Leishmania. The estimated number of deaths from visceral leishmaniases ranges from 20,000 to 50,000 annually. The most common treatment over the past 60 years has been pentavalent antimonials. Besides the doubtful...
1 - 1 of 1